Stay updated on Timing of Pembrolizumab in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Timing of Pembrolizumab in NSCLC Clinical Trial page.

Latest updates to the Timing of Pembrolizumab in NSCLC Clinical Trial page
- CheckyesterdayChange DetectedThe clinical trial record was updated with changes to its study status and contacts/locations, and a new version was added to its history.SummaryDifference0.1%

- Check8 days agoChange DetectedThe site footer revision changed from v3.7.1 to v3.7.2.SummaryDifference0.0%

- Check15 days agoChange DetectedThe site footer now displays revision v3.7.1 instead of v3.7.0.SummaryDifference0.0%

- Check22 days agoChange DetectedNew study-record versions dated September 26 and September 30, 2026, are listed, with updates to study status and contacts/locations. The September 21 date no longer appears in the history.SummaryDifference0.1%

- Check29 days agoChange DetectedThe history now includes new submissions dated 2026-09-18 and 2026-09-21, adding Study Status and Study Identification sections to the record. An entry dated 2026-08-28 was removed from the history, indicating an adjustment to the version history of the study.SummaryDifference0.0%

- Check36 days agoChange DetectedThe Record History page now shows Revision: v3.7.0, replacing the previous v3.6.6, indicating a refreshed version of the study history.SummaryDifference0.0%

Stay in the know with updates to Timing of Pembrolizumab in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Timing of Pembrolizumab in NSCLC Clinical Trial page.